DIVERGIMAB

Welcome to the Brand page for “DIVERGIMAB”, which is offered here for Scientific research services for others in the field of genetics and monoclonal antibodies; research and development services in the field of monoclonal antibodies, development of antibody-based therapeutics and discovery of reagents; research and development services in the field of monoclonal antibodies, generation of therapeutic and reagent antibodies; genetic engineering services, the production of genetically-engineered mice and monoclonal antibodies for others;.

Its status is currently believed to be active. Its class is unavailable. “DIVERGIMAB” is believed to be currently owned by “AbX Biologics, Inc.”